Pfizer comes to the rescue of the EU after suspension of AstraZeneca vaccine

The vaccination campaign in Europe is on the way to becoming a roller coaster of emotions. In the midst of the crisis of the 27 member states of the EU due to the increasingly widespread decision among members to stop immunization with AstraZeneca due to cases of strange embolisms, and when the continent saw its promise to get 70% of the European population vaccinated for late summer, Pfizer has come to the rescue. The German-American consortium informed the European Commission today (Tuesday) that they will deliver more than 200 million doses in the second quarter, from April.

The new forecasts assume that the EU will receive 10 million more doses, which, until now, would not arrive until the third and fourth quarters, but above all, Spanish Ministry of Health officials acknowledged this morning, is a "confirmation" that Pfizer, after the supply problems in the first quarter due to the readjustments in production, will be able to meet its commitments. “This is very good news. It gives member states room to manoeuvre and possibly fill the gaps in deliveries," said EU Commission President Ursula von der Leyen.